Evidence map›Paper›PMID 15596833›Full record

ArticleJournal of virology2005

Dendritic cells and macrophages are productively infected by poliovirus.

Rahnuma Wahid, Martin J Cannon, Marie Chow

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 86 citations in OpenAlex.

  1. Trial
  2. Viral Microglia Reprogramming Clears Oligomeric Neurotoxic Debris.bioRxiv : the preprint server for biology · 2026
    Article
  3. Polio virotherapy provokes MDA5 signaling and CD4Microbiology and molecular biology reviews : MMBR · 2025
    Review
  4. Unraveling the complexities of neurotropic virus infection and immune evasion.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  5. Article
  6. Article
  7. Immunomodulatory properties ofFrontiers in immunology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. HIV-1-Infected CD4Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Recombinant poliovirus for cancer immunotherapy.Annals of translational medicine · 2018
    Article
  19. Recombinant Poliovirus for Cancer Immunotherapy.Annual review of medicine · 2018
    Review
  20. Regulation of IgMFrontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rahnuma WahidDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Martin J Cannon
Marie Chow
University of Arkansas for Medical Sciences · US

Funding

EARLY STAGES OF INFECTION BY NONENVELOPED VIRUSESR01AI042390 · NIAID · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI CHOW, MARIE · 1998 to 2002
$961k
MOLECULAR ANALYSIS OF POLIOVIRUS NEUTRALIZING EPITOPESR01AI022627 · NIAID · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI CHOW, MARIE · 1985 to 1999
–
NIAID NIH HHS AI22627NIAID NIH HHS AI42390NIAID NIH HHS R01 AI042390
6 · The paper itself

Abstract

Expression of the poliovirus receptor (PVR) on cells is a major host determinant of infection by poliovirus. Previously, the only immune cell type known to express PVR was the blood-derived monocyte, which is susceptible to infection at very low frequency. We demonstrate that professional antigen-presenting cells-macrophages and dendritic cells, generated upon differentiation of monocytes-retain expression of PVR and are highly susceptible to infection by type 1 Mahoney strain of poliovirus. Maximal cell-associated titers of virus are obtained within 6 to 8 h postinfection, and cell death and lysis occurs within 24 h postinfection. Similar kinetics are observed in cells infected with the Sabin 1 vaccine strain. Although protein synthesis and receptor-mediated endocytosis are inhibited upon poliovirus infection of these critical antigen-presenting cells, we demonstrate for the first time that functional presentation of antigen occurs in these infected cells via the HLA class II pathway.

Indexed as

Poliovirus Vaccine, OralAntigen PresentationApoptosisCD8-Positive T-LymphocytesCells, CulturedDendritic CellsEndocytosisHistocompatibility Antigens Class IIHumansMacrophagesMonocytesPoliovirusProteinsHistocompatibility Antigens Class IIPoliovirus Vaccine, OralProteins

Identifiers

PMID15596833
PMCPMC538697
OpenAlexW2121204397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.